UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 419

Sortiert nach

Atorvastatin and Micronized Fenofibrate Alone and in Combination in Type 2 Diabetes With Combined Hyperlipidemia

Diabetes care, 2002-07, Vol.25 (7), p.1198-1202

2002

Link zum Volltext

Verfügbarkeit prüfen

Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population

Current medical research and opinion, 2010-03, Vol.26 (3), p.713-719

2010

Link zum Volltext

Verfügbarkeit prüfen

Long-term treatment effect of atorvastatin on aortic stiffness in hypercholesterolaemic patients

Current medical research and opinion, 2003, Vol.19 (1), p.22-27

2003

Link zum Volltext

Verfügbarkeit prüfen

Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome

Nephrology, dialysis, transplantation, 2007-01, Vol.22 (1), p.118-127

2007

Link zum Volltext

Verfügbarkeit prüfen

Treatment with Atorvastatin to the National Cholesterol educational program goal versus 'usual' care in secondary coronary heart disease prevention: The greek Atorvastatin and coronary-heart-disease evaluation (GREACE) study

Current medical research and opinion, 2002, Vol.18 (4), p.220-228

2002

Link zum Volltext

Verfügbarkeit prüfen

Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome : A subgroup analysis of the GREek atorvastatin and Coronary heart disease Evaluation (GREACE) Study

Nephrology, dialysis, transplantation, 2007-01, Vol.22 (1), p.118-127

2007

Link zum Volltext

Verfügbarkeit prüfen

Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the greek atorvastatin and coronary-heart-disease evaluation (GREACE) study

American journal of kidney diseases, 2004-04, Vol.43 (4), p.589-599

2004

Link zum Volltext

Verfügbarkeit prüfen

Association of Drinking Pattern and Alcohol Beverage Type With the Prevalence of Metabolic Syndrome, Diabetes, Coronary Heart Disease, Stroke, and Peripheral Arterial Disease in a Mediterranean Cohort

Angiology, 2007-12, Vol.58 (6), p.689-697

2007

Link zum Volltext

Verfügbarkeit prüfen

Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients

The open cardiovascular medicine journal, 2007-01, Vol.1 (1), p.8-14

2007

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study

Current medical research and opinion, 2004-11, Vol.20 (11), p.1691-1701

2004

Link zum Volltext

Verfügbarkeit prüfen

Atorvastatin Decreases Triacylglycerol-Associated Risk of Vascular Events in Coronary Heart Disease Patients

Lipids, 2007-11, Vol.42 (11), p.999-1009

2007

Link zum Volltext

Verfügbarkeit prüfen

Targeting vascular risk in patients with metabolic syndrome but without diabetes

Metabolism, clinical and experimental, 2005-08, Vol.54 (8), p.1065-1074

2005

Link zum Volltext

Verfügbarkeit prüfen

Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease

Atherosclerosis, 2001-08, Vol.157 (2), p.463-469

2001

Link zum Volltext

Verfügbarkeit prüfen

Effect of quinapril or metoprolol on heart rate variability in post-myocardial infarction patients

The American journal of cardiology, 1996-02, Vol.77 (4), p.242-246

1996

Link zum Volltext

Verfügbarkeit prüfen

Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study

Current medical research and opinion, 2004-05, Vol.20 (5), p.627-637

2004

Link zum Volltext

Verfügbarkeit prüfen

Early Benefit from Structured Care with Atorvastatin in Patients with Coronary Heart Disease and Diabetes Mellitus: A Subgroup Analysis of the GREek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study

Angiology, 2003-11, Vol.54 (6), p.679-690

2003

Link zum Volltext

Verfügbarkeit prüfen

Early benefit from structured care with atorvastatin in patients with coronary heart disease and diabetes mellitus

Angiology, 2003-11, Vol.54 (6), p.679-690

2003

Link zum Volltext

Verfügbarkeit prüfen

Statins and renal function in patients with diabetes mellitus

Current medical research and opinion, 2003, Vol.19 (7), p.615-617

2003

Link zum Volltext

Verfügbarkeit prüfen

Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study

Current medical research and opinion, 2008-06, Vol.24 (6), p.1593-1599

2008

Link zum Volltext

Verfügbarkeit prüfen

Safety and Efficacy of Long-Term Statin-Fibrate Combinations in Patients With Refractory Familial Combined Hyperlipidemia

The American journal of cardiology, 1997-09, Vol.80 (5), p.608-613

1997

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis of osteoporosis in liver cirrhosis

Hepato-gastroenterology, 2006-11, Vol.53 (72), p.938

2006

Link zum Volltext

Verfügbarkeit prüfen

Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy

Diabetes care, 1997-03, Vol.20 (3), p.355

1997

Link zum Volltext

Verfügbarkeit prüfen

Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study

Platelets (Edinburgh), 2005-03, Vol.16 (2), p.65-71

2005

Link zum Volltext

Verfügbarkeit prüfen

Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

Current medical research and opinion, 2004-09, Vol.20 (9), p.1385-1392

2004

Link zum Volltext

Verfügbarkeit prüfen

Statin-fibrate combinations in patients with combined hyperlipidemia

Atherosclerosis, 2001-03, Vol.155 (1), p.263-264

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 419

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(345)
Mit Volltextzugriff
(362)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Atorvastatin and Micronized Fenofibrate Alone and in Combination in Type 2 Diabetes With Combined Hyperlipidemia

Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population

Long-term treatment effect of atorvastatin on aortic stiffness in hypercholesterolaemic patients

Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome

Treatment with Atorvastatin to the National Cholesterol educational program goal versus 'usual' care in secondary coronary heart disease prevention: The greek Atorvastatin and coronary-heart-disease evaluation (GREACE) study

Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome : A subgroup analysis of the GREek atorvastatin and Coronary heart disease Evaluation (GREACE) Study

Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the greek atorvastatin and coronary-heart-disease evaluation (GREACE) study

Association of Drinking Pattern and Alcohol Beverage Type With the Prevalence of Metabolic Syndrome, Diabetes, Coronary Heart Disease, Stroke, and Peripheral Arterial Disease in a Mediterranean Cohort

Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients

Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study

Atorvastatin Decreases Triacylglycerol-Associated Risk of Vascular Events in Coronary Heart Disease Patients

Targeting vascular risk in patients with metabolic syndrome but without diabetes

Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease

Effect of quinapril or metoprolol on heart rate variability in post-myocardial infarction patients

Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study

Early Benefit from Structured Care with Atorvastatin in Patients with Coronary Heart Disease and Diabetes Mellitus: A Subgroup Analysis of the GREek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study

Early benefit from structured care with atorvastatin in patients with coronary heart disease and diabetes mellitus

Statins and renal function in patients with diabetes mellitus

Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study

Safety and Efficacy of Long-Term Statin-Fibrate Combinations in Patients With Refractory Familial Combined Hyperlipidemia

Pathogenesis of osteoporosis in liver cirrhosis

Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy

Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study

Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

Statin-fibrate combinations in patients with combined hyperlipidemia

Suchergebnisse filtern